Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Alpers

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
American Journal of Human Genetics|March 20, 2024
Population structure and migration in the Eastern Highlands of Papua New Guinea, a region impacted by the kuru epidemicLiam Quinn, Jerome Whitfield, Michael P Alpers, et al.
Filaria Journal|October 4, 2003
Spatial variation of Anopheles-transmitted Wuchereria bancrofti and Plasmodium falciparum infection densities in Papua New GuineaNeal D Alexander, Rana A Moyeed, Phil J Hyun, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 14, 2008
Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion diseaseSebastian Brandner, Jerome Whitfield, Ken Boone, et al.
Plos One|October 14, 2017
Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccinationAnita H J van den Biggelaar, Peter C Richmond, Angela Fuery, et al.
Science (New York, N.Y.)|September 16, 2017
A Neolithic expansion, but strong genetic structure, in the independent history of New GuineaAnders Bergström, Stephen J Oppenheimer, Alexander J Mentzer, et al.
The New England Journal of Medicine|November 20, 2009
A novel protective prion protein variant that colocalizes with kuru exposureSimon Mead, Jerome Whitfield, Mark Poulter, et al.
Plos One|March 2, 2013
Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trialWilliam S Pomat, Anita H J van den Biggelaar, Suparat Phuanukoonnon, et al.
The Lancet. Neurology|December 17, 2008
Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association studySimon Mead, Mark Poulter, James Uphill, et al.
Vaccine|November 8, 2003
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean childrenBlaise Genton, Fadwa Al-Yaman, Inoni Betuela, et al.
The Journal of Infectious Diseases|March 29, 2002
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New GuineaBlaise Genton, Inoni Betuela, Ingrid Felger, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
American Journal of Human Genetics|March 20, 2024
Population structure and migration in the Eastern Highlands of Papua New Guinea, a region impacted by the kuru epidemicLiam Quinn, Jerome Whitfield, Michael P Alpers, et al.
Filaria Journal|October 4, 2003
Spatial variation of Anopheles-transmitted Wuchereria bancrofti and Plasmodium falciparum infection densities in Papua New GuineaNeal D Alexander, Rana A Moyeed, Phil J Hyun, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 14, 2008
Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion diseaseSebastian Brandner, Jerome Whitfield, Ken Boone, et al.
Plos One|October 14, 2017
Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccinationAnita H J van den Biggelaar, Peter C Richmond, Angela Fuery, et al.
Science (New York, N.Y.)|September 16, 2017
A Neolithic expansion, but strong genetic structure, in the independent history of New GuineaAnders Bergström, Stephen J Oppenheimer, Alexander J Mentzer, et al.
The New England Journal of Medicine|November 20, 2009
A novel protective prion protein variant that colocalizes with kuru exposureSimon Mead, Jerome Whitfield, Mark Poulter, et al.
Plos One|March 2, 2013
Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trialWilliam S Pomat, Anita H J van den Biggelaar, Suparat Phuanukoonnon, et al.
The Lancet. Neurology|December 17, 2008
Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association studySimon Mead, Mark Poulter, James Uphill, et al.
Vaccine|November 8, 2003
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean childrenBlaise Genton, Fadwa Al-Yaman, Inoni Betuela, et al.
The Journal of Infectious Diseases|March 29, 2002
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New GuineaBlaise Genton, Inoni Betuela, Ingrid Felger, et al.
Pageof 7